Benefit-Risk Assessment Based on Number Needed to Treat and Number Needed to Harm: Atogepant vs Calcitonin Gene–Related Peptide Monoclonal Antibodies (P5-12.007)

Simona Sacco, Anjana Lalla,Rashmi Halker Singh, Dagney Holle-Lee,Patricia Pozo-Rosich, Krisztian Nagy, Kari Kelton, Cristiano Piron,Pranav Gandhi,Jessica Ailani

Neurology(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要